DMAC
DiaMedica Therapeutics Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 9:44:50 AM EST
8.56USD-0.349%(-0.03)6,565
DMAC Financials
In Q3 FY 2026 (ended ), DiaMedica Therapeutics Inc. Common Stock (DMAC) reported net income of −$11.31M, operating cash flow of −$8.83M, and assets of $36.15M (filed ).
Loading financial flows…